Literature DB >> 17472536

The role of established and emerging risk factors in peripheral vascular graft occlusion.

E M Fatourou1, K I Paraskevas, A M Seifalian, G Hamilton, D P Mikhailidis.   

Abstract

Several studies have evaluated the association between established as well as emerging vascular risk factors with peripheral graft occlusion. There is evidence for a link between the risk for graft occlusion and total serum cholesterol, low-density lipoprotein cholesterol and triglyceride levels. The overall effect of smoking shows a 2.35-fold increase in risk of graft failure. Studies involving diabetic patients undergoing peripheral bypass may have failed to detect higher occlusion rates, possibly due to increased morbidity and mortality as well as higher amputation rates even if the graft is patent. Both antiplatelet agents and anticoagulation seem to be effective in the prevention of graft occlusion. Unconvincing data have been published with regards to the effect of hypertension on graft patency. Emerging factors such as fibrinogen, lipoprotein (a), C-reactive protein and homocysteine levels should also be considered when assessing the risk of graft occlusion. More research is needed to prevent graft occlusion due to the obvious clinical relevance, quality of life and cost issues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472536     DOI: 10.1517/14656566.8.7.901

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  2 in total

1.  Pulsed high-intensity-focused US and tissue plasminogen activator (TPA) versus TPA alone for thrombolysis of occluded bypass graft in swine.

Authors:  Nadine Abi-Jaoudeh; William F Pritchard; Hayet Amalou; Marius Linguraru; Oscar A Chiesa; Joshua D Adams; Carmen Gacchina; Robert Wesley; Subha Maruvada; Briana McDowell; Victor Frenkel; John W Karanian; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2012-05-19       Impact factor: 3.464

2.  One of the most urgent vascular circumstances: Acute limb ischemia.

Authors:  Rezzan D Acar; Muslum Sahin; Cevat Kirma
Journal:  SAGE Open Med       Date:  2013-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.